The Cryotherapy for Retinopathy of Prematurity (CRYO-ROP) study is a multicenter study involving 23 centers and more than 100 physicians and study center coordinators throughout the United States. The goal of the study is to evaluate the safety and efficacy of retinal ablative cryotherapy for the prevention of retinal detachment and blindness in infants with severe ROP . More than 4,000 infants with birth weights <1251 grams were enrolled in the natural history portion of the study between January 1986 and November 1987. Approximately two-thirds of the infants developed ROP and one-third did not. Two hundred ninety-one infants developed severe ROP and were enrolled in the randomized trial of cryotherapy. All infants in the randomized trial and more than 1,000 of the remaining infants in the natural history part of the study had retinal status evaluated at ages 3 months and 1 year using fundus photographs , and at 3 months, 1, 2, 31/2, 41/2, and 51/2 years by physician's examination of the posterior pole of the retina . Visual acuity was evaluated using the Teller acuity card procedure at ages 1, 2, 31/2 , 41/2, and 51/2 years, using the crowded HOTV letter acuity chart or cards at 31/2 and 41/2 years, and using the ETDRS logMAR letter acuity charts at 51/2 years. Testing was with optical correction, if needed. This paper describes visual acuity results from children who were participants in the CRYO-ROP study. The first section presents data from the large number of children in the natural history cohort, showing that the development of grating visual acuity depends on the severity of cicatricial ROP (e.g., abnormally straightened temporal retinal blood vessels , macular ectopia, retinal fold or detachment). The second part presents at comparison of grating acuity results with HOTV letter acuity results collected a ages 31/2 and 41/2 years from children in the natural history portion of the study. The final section presents results for grating acuity, HOTV letter acuity , and ETDRS l etter acuity testing conducted at ages 1, 31/2 and 51/2 years, respectively, in eyes that underwent cryotherapy for severe ROP, as compared with eyes that had severe ROP but did not undergo cryotherapy. Data at all three ages were consistent in showing a clear benefit of cryotherapy in preserving visual function. However, the data also indicated that eyes in which cryotherapy has prevented blindness often do not develop visual acuity that is within the normal range when a child reaches 31/2 to 51/2 years of age.
).
The second group of infants enrolled in the CRYO-ROP study was the randomized cohort. This group consisted of 218 of the infants in the natural history cohort, plus 73 infants from non-study hospitals who were enrolled into the randomized cohort after they developed severe ROP. All infants in the randomized group developed severe ("threshold") ROP, i.e., ROP that was so severe that, if left untreated, it would be expected to produce retinal detachment and blindness in 50% of eyes. These infants who developed threshold ROP participated in the randomized trial of cryotherapy for ROP. In the randomized trial, 240 infants with threshold ROP in both eyes had one eye randomly assigned to cryotherapy and one eye randomly assigned to no cryotherapy. The 51 infants who had threshold ROP in only one eye had that eye randomly assigned to cryotherapy or to no cryotherapy.
Mean birth weight of the group of 291 randomized infants was 800 grams, and mean no/mild residua category was also identified.
Eyes in this subset were those with abnormal straightening of the temporal retinal vessels.
As shown in Figure  2 , visual acuity results from eyes with quantifiable grating acuity were related to severity of retinal residua of ROP.
Eyes that developed ROP but later showed no or only mild peripheral residua showed an average grating acuity that was similar at all ages to that of eyes in which no evidence of acute-phase ROP was ever found. However, In infants, it is not possible to measure recognition (letter) visual acuity. However, by about age 3 years, many children can match letters, so that they can be tested with a simplified letter acuity test. One letter acuity test that has been developed for use with young children is the Crowded HOTV chart and cards (Good-Lite, Chicago, Illinois, USA). Figure   3 shows the difference (in octaves) between the HOTV score and the grating acuity score in eyes with macular heterotopia, tested at age 41/2 years. Acuity scores for the two types of tests were equated based on the convention that 6/6 (20/20) letter acuity is equivalent to grating acuity of 30 cycles/degree. As shown in Figure   3 , the difference between letter acuity and grating acuity in normal eyes rarely exceeded 0.75 octave, and on average, HOTV acuity was 0.27 octave better than grating in these eyes. For data analysis, acuity scores were classified as "favorable" or "unfavorable". Favorable grating acuity scores were those that were within the normal range or no more than 1 octave below the normal range, based on the child's age. Unfavorable grating acuity scores were those that were more than 1 octave below the normal range, based on age. At age 1 year, unfavorable grating acuity scores were those that were worse than 0.8 cycles/degree. The results shown in Figure 5 indicate that , at age 1 year, the distribution of acuity results was bimodal: eyes were either blind or showed acuity in the normal range for a 1-year-old .
There were more treated eyes than control eyes with acuity in the normal range, and fewer treated eyes than control eyes that were blind.
Thus, eyes that were saved from blindness by cryotherapy showed acuity in the normal range at age 1 year.
As shown in Figure 6 , the results were 
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